Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Clinical trial NCT06931613 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06931613
Sponsor: St. Petersburg State Pavlov Medical University
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Hodgkin Lymphoma Children Nivolumab Autologous Haemopoietic Stem Cell Transplant

Start date: 2022-06-01
Primary completion: 2026-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.